探索心力衰竭和功能衰竭之间的潜在因果关系和分子机制:孟德尔随机化研究,MIMIC-IV数据库和GEO数据库的见解
Journal of vascular research
|August 28, 2025
概括
心力衰竭显著增加功能衰竭的风险,这表明存在因果关系. 基因和分子分析确定了微生物,新陈代谢和免疫途径作为心综合征的潜在治疗点.
科学领域:
- 遗传学
- 心脏病学
- 肝脏病学
背景情况:
- 心脏衰竭 (HF) 和功能衰竭 (RF) 经常同时存在,形成心脏功能综合征.
- 连接HF和RF的因果机制尚不清楚.
研究的目的:
- 使用遗传数据调查高频对射频的因果关系.
- 确定心脏脏综合征的潜在治疗点.
主要方法:
- 孟德尔随机化 (MR) 与全基因组关联研究 (GWAS) 数据集.
- 逆差加权 (IVW) 和基于总结数据的MR (SMR) 分析.
- 肠道微生物群,血清代谢物和转录组数据的分析;与MIMIC-IV数据库进行验证.
主要成果:
- HF显著增加了射频风险 (OR = 1.54).
- 确定SURF1和MAP3K11是潜在的治疗点.
- 发现了一种肠道微生物和一种血清代谢物的因果关系.
- 转录组分析揭示了MAPK级联中的11个差异表达基因,其中RELA是关键的转录因子.
结论:
- 提供HF在RF中的因果作用的遗传和分子证据.
- 突出了微生物,代谢和免疫机制作为心综合征的潜在治疗点.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure Drugs: Diuretics
483
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
483
Heart Failure II: Pathophysiology
37
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
37
Heart Failure I: Introduction
52
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
52
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23


